This special session will provide an opportunity for bidirectional communication between NIAAA, NIDA and AHRQ representatives and clinicians/clinician-researchers about how to address the divide between research and clinical practice, as well as emerging topics in addiction medicine research. Funding agency representatives will solicit clinicians’ feedback on which areas of research should be prioritized to improve clinical practice and access to treatment. Clinicians/clinician-researchers will learn about opportunities for increasing their participation in research. Participants also will engage in brainstorming about how to include more clinical voices in the shaping of addiction research priorities.
Representatives of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), and Agency for Healthcare Research and Quality (AHRQ) have requested input from ASAM members on how to improve the clinical relevance of their addiction medicine research portfolios. Please provide input on their questions here.